Table of Contents
ISRN Infectious Diseases
Volume 2013 (2013), Article ID 154921, 3 pages
http://dx.doi.org/10.5402/2013/154921
Research Article

Prevalence of Metallo-β-Lactamases Producing Acinetobacter baumannii in a Moroccan Hospital

1Laboratory of Microbiology, Hospital of Specialties, Ibn Sina University Hospital, Rabat, Morocco
2Faculty of Medicine and Pharmacy, University Mohammed V Souissi, Rabat, Morocco
3Intensive Care Unit, Hospital of Specialties, Ibn Sina University Hospital, Rabat, Morocco

Received 12 September 2012; Accepted 8 October 2012

Academic Editors: A. Carvalho and A. Pop-Vicas

Copyright © 2013 Hakima Kabbaj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. C. Maltezou, “Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?” International Journal of Antimicrobial Agents, vol. 33, no. 5, pp. 405.e1–405.e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Peymani, M. R. Nahaei, S. Farajnia et al., “High prevalence of metallo-β-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran,” Japanese Journal of Infectious Diseases, vol. 64, no. 1, pp. 69–71, 2011. View at Google Scholar · View at Scopus
  3. V. Gupta, P. Datta, and J. Chander, “Prevalence of metallo-β lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India,” Journal of Infection, vol. 52, no. 5, pp. 311–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Yong, K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong, “Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.,” Journal of Clinical Microbiology, vol. 40, no. 10, pp. 3798–3801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ait el kadi, M. Aghrouch, M. Seffar et al., “Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-β-lactamase,” Medecine et Maladies Infectieuses, vol. 36, no. 7, pp. 386–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Elouennas, T. Bajou, A. H. Lemnouer, V. Foissaud, V. Hervé, and A. J. Baaj, “Acinetobacter baumannii: susceptibility of strains identified in the military instruction hospital Mohammed V, Rabat, Morocco,” Medecine et Maladies Infectieuses, vol. 33, no. 7, pp. 361–364, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Lahsoune, H. Boutayeb, K. Zerouali, H. Belabbes, and N. El Mdaghri, “Prevalence and in vitro antimicrobial susceptibility patterns of Acinetobacter baumannii strains in a Moroccan university hospital,” Medecine et Maladies Infectieuses, vol. 37, no. 12, pp. 828–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo, “Global challenge of multidrug-resistant Acinetobacter baumanni,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 10, pp. 3471–3484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Principe, S. D'Arezzo, A. Capone, N. Petrosillo, and P. Visca, “In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii,” Annals of Clinical Microbiology and Antimicrobials, vol. 8, article 18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Jin, X. M. Xu, Z. H. Mi, Y. Mou, and P. Liu, “Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings,” Chinese Medical Journal, vol. 122, no. 3, pp. 301–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Baran, A. Erbay, H. Bodur et al., “Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections,” International Journal of Infectious Diseases, vol. 12, no. 1, pp. 16–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Lee, D. Yong, S. H. Jeong, and Y. Chong, “Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens,” Yonsei Medical Journal, vol. 52, no. 6, pp. 879–891, 2011. View at Google Scholar
  13. K. Lee, W. G. Lee, Y. Uh, G. Y. Ha, and J. Cho, “VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp.in Korean hospitals,” Emerging Infectious Diseases Journal, vol. 9, pp. 868–871, 2003. View at Google Scholar
  14. M. Watanabe, S. Iyobe, M. Inoue, and S. Mitsuhashi, “Transferable imipenem resistance in Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 35, no. 1, pp. 147–151, 1991. View at Google Scholar · View at Scopus
  15. S. John and R. Baragurunathan, “Metallo beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii,” Indian Journal of Medical Microbiology, vol. 29, no. 3, pp. 302–304, 2011. View at Google Scholar
  16. F. Kaleem, J. Usman, A. Hassan, and A. Khan, “Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan,” Journal of Infection in Developing Countries, vol. 4, no. 12, pp. 810–813, 2010. View at Google Scholar · View at Scopus
  17. S. Irfan, A. Zafar, D. Guhar, T. Ahsan, and R. Hasan, “Metallo-β-lactamase-producing clinical isolates of Acinetobacter species and Pseudomonas aeruginosa from intensive care unit patients of a tertiary care hospital,” Indian Journal of Medical Microbiology, vol. 26, no. 3, pp. 243–245, 2008. View at Publisher · View at Google Scholar · View at Scopus